D.E. Shaw & Co’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.52M | Sell |
695,031
-298,330
| -30% | -$653K | ﹤0.01% | 2037 |
|
2025
Q1 | $1.35M | Buy |
993,361
+978,327
| +6,507% | +$1.33M | ﹤0.01% | 2036 |
|
2024
Q4 | $20K | Buy |
+15,034
| New | +$20K | ﹤0.01% | 2875 |
|
2024
Q1 | – | Sell |
-108,168
| Closed | -$153K | – | 3122 |
|
2023
Q4 | $153K | Buy |
+108,168
| New | +$153K | ﹤0.01% | 2725 |
|
2023
Q1 | – | Sell |
-17,090
| Closed | -$45.5K | – | 3299 |
|
2022
Q4 | $45.5K | Sell |
17,090
-88,273
| -84% | -$235K | ﹤0.01% | 3203 |
|
2022
Q3 | $349K | Sell |
105,363
-287,574
| -73% | -$953K | ﹤0.01% | 3020 |
|
2022
Q2 | $1.43M | Buy |
392,937
+172,696
| +78% | +$628K | ﹤0.01% | 2486 |
|
2022
Q1 | $1.12M | Buy |
220,241
+27,725
| +14% | +$141K | ﹤0.01% | 2800 |
|
2021
Q4 | $1.47M | Buy |
+192,516
| New | +$1.47M | ﹤0.01% | 2544 |
|